For patients with head and neck cancer, treatment can come at a high cost to their quality of life, affecting their ability to speak, swallow and even breathe due to invasive procedures. Now, Penn State researchers have developed a light-activated nanoparticle system with the long-term goal of shrinking tumors while limiting exposure to healthy tissue and improving patients' quality of life after cancer treatment. Penn State has licensed the technology to Illuminate Therapeutics, which is advancing its preclinical development.
❓ Unknown
Light-activated nanoparticles may help treat head and neck cancer
Just now
November 20, 2026
1 min read
📰 Phys.org
📋 Key Takeaway
This article discusses Penn State researchers developing light-activated nanoparticles for treating head and neck cancer, with the technology licensed to Illuminate Therapeutics. The research aims to improve cancer treatment outcomes while minimizing damage to healthy tissue. This article contains no information relevant to Iranian affairs or politics.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
Just now •
Davoud Rokhbin Executed for Murder in Kashan Prison
Just now •
Ali Mokhtari Executed for Rape in Shahre Kord
7 min ago •
The surprising cancer connection at the heart of Alzheimer's
17 min ago •
Volunteering delivers purpose—but also anxiety
17 min ago •